BCL2 and hepatocellular carcinoma: These results suggested that sinularin could enhance cellular and mtROS through the inhibition of the antioxidant enzymes in HCC cells while reducing the mitochondrial membrane potential, resulting in a significant outspread of the Bcl-2 protein family, including pro-apoptotic molecules and anti-apoptotic molecules.